A Clinically-Curated Algorithmic Workflow Mimicking Expert Reasoning for Objective and Operator-Independent CNV Classification and Reporting
Speaker: Agnese Feresin – Reproductive Precision Medicine Unit, Menarini Silicon Biosystems
11:08 AM - 11:15 AM East Coast USA Time
Nipocalimab versus Placebo to Prevent Severe Hemolytic Disease of the Fetus and Newborn (AZALEA): A Randomized, Double‑Blind, Placebo‑Controlled Phase 3 Trial
Best Early Career Investigators and Joe Leigh Simpson Award
12:00 PM - 12:45 PM East Coast USA Time
Best Early Career Investigators and Joe Leigh Simpson Award
12:00 PM - 12:15 PM East Coast USA Time
Two sides of the same coin? Prenatal genomic testing has major clinical impact but unsolicited findings increase adverse parental psychological outcomes
